We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
-19.38%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$398M
AUM Growth
-$344M
(-46%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-62.23%
Top 10 Holdings %
Top 10 Hldgs %
44.07%
Holding
188
New
36
Increased
27
Reduced
23
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$14.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$10.8M |
| 3 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$9.74M |
| 4 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$9.08M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$8.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$27M |
| 2 |
Knight Transportation
KNX
|
+$17.2M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$15.8M |
| 4 |
Magnolia Oil & Gas
MGY
|
+$14.6M |
| 5 |
ADMS
Adamas Pharmaceuticals
ADMS
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.17% |
| 2 | Healthcare | 20.63% |
| 3 | Industrials | 11.87% |
| 4 | Utilities | 10.14% |
| 5 | Consumer Staples | 5.21% |
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Ardsley Advisory Partners held 188 positions worth $398M, down 46% from $742M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Ardsley Advisory Partners withdrew a net $248M in Q4 2018, closing 84 positions and reducing 23 holdings. Its most notable exit was Marathon Petroleum, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ardsley Advisory Partners opened a new position in CVS Health worth $12.8M.
- Ardsley Advisory Partners's largest Q4 2018 buy was CVS Health: 195,000 shares worth $12.8M.
- Ardsley Advisory Partners added most to Celgene Corp in Q4 2018, an estimated $10.8M increase.
- Ardsley Advisory Partners's biggest Q4 2018 reduction was Progenics Pharmaceuticals Inc, cutting an estimated $7.73M.
- Ardsley Advisory Partners fully exited Marathon Petroleum in Q4 2018, selling an estimated $27M.
- Ardsley Advisory Partners's ten largest holdings make up 44% of its $398M portfolio in Q4 2018.
- Ardsley Advisory Partners opened 36 new positions and closed 84 in Q4 2018.
- Ardsley Advisory Partners's portfolio value fell 46% quarter-over-quarter to $398M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2018, filed 14 Feb 2019.